Sep 5 2011
According to the resolution by the Annual General Meeting on 23 May 2011, the Board of Directors in DiaGenic ASA (OSE:DIAG) today allotted options to DiaGenic employees. The share options have strike price of NOK 6.00 per share, which is set based on last week weighted share price + 10%. The options have life of 4 years and can be exercised after 3 years.
The following primary insiders have today been allotted options:
· Erik Christensen, CEO: 120,000 options
· Magnus Sjøgren, Medical Director: 40,000 options
· Morten Sten Johansen, International Business Director: 40,000 options
· Edith Rian, Director Operations: 40,000 options
· Ruben Ekbråten, Finance Director: 40,000 options
· Anders Lönneborg, Research Director: 16,000 options
· Praveen Sharma, Head of IP : 16,000 options
· Gisle Grave, Clinical R&D Director: 16,000 options
· Torbjørn Lindahl, Bioinformatics Manager: 16,000 options
· Line Røed, Senior Scientist: 16,000 options
Today a total of 432,000 options have been allotted, including allotments listed above. After the allotment today, DiaGenic have a total of 432,000 options outstanding.